Thank you to all who joined us live Primary Care Pulse on July 20, 2021. If you were not able to join us live, the sessions have been recorded and are available below.
Upcoming Virtual Programs
Agenda
CME/CE Accredited Session
Non-CME/CE Session
Sponsored by Industry
Click For Session Details
Session Times Listed in ET
12–12:30pm ET CME/CE Accredited Session
COVID-19 Web Series Part 30: Vaccinating Individuals with Impaired Immunity and Monoclonal Antibodies
Ty J. Gluckman, MD, FACC, FAHA | Charles Vega, MD, FAAFP
With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss how seropositivity levels can vary after vaccination and which patients would make good candidates for monoclonal antibodies (mAbs). You’ll also hear the latest clinical trials data on the efficacy of mAbs.
Ty J. Gluckman, MD, FACC, FAHA
Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS) , Providence Heart Institute, Providence , St. Joseph Health, Portland, OR ,
Charles Vega, MD, FAAFP
Health Sciences Clinical Professor , UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA,
12:35–1:20pm ET Non-CME Industry Theater
HPV and Head and Neck Cancers: Do You Know the Facts?
John Chan, MD
• Understand the prevalence of certain HPV-related head and neck cancers in the United States
• Review recommendations and guidelines from major medical societies
• Discuss the importance of educating patients about HPV and HPV-related head and neck cancers
John Chan, MD
John Chan, MD is the Chair, California Pacific Medical Center, Regional Director at Palo Alto Medical Foundation and Lead Principal Investigator at Sutter Cancer Research Consortium. Dr. Chan attended University of California (UC) at Los Angeles, School of Medicine and completed his residency in obstetrics and gynecology and subsequent fellowship in gynecologic oncology at UC, Irvine. Board certified in Obstetrics & Gynecology. Dr. Chan also has subspecialty certification in Gynecologic Oncology. He is an Adjunct Clinical Professor with the Division of Gynecologic Oncology at the Helen Diller Family Comprehensive Cancer Center at UC, San Francisco and retains this academic appointment at Stanford University School of Medicine and Geisel School of Medicine at Dartmouth. Dr. Chan is an international speaker on topics relating to gynecologic cancer and women's health. He has been published and is an ad hoc reviewer for an extensive number of peer reviewed scientific journals.
Sponsored by Merck